Dr. Yali Shen 沈亚丽
Chief Physician
Department of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy for abdominal tumors, including digestive system, urinary, reproductive system, and gynecologic cancers.
Dr. Shen graduated from West China School of Medicine, Sichuan University in 2001. As a Chief Physician, Dr. Shen focuses on clinical care, teaching, and research in comprehensive cancer treatment. Expertise includes 3D conformal radiation therapy, intensity-modulated radiation therapy, stereotactic body radiation therapy, and image-guided radiation therapy (IGRT). Dr. Shen has published over ten papers, participated in two provincial research projects, and joined multiple domestic and international clinical trials.
Professional roles
- Member, Chinese Medical Association
Name order: in Chinese the family name comes first (Shen Yali). Papers usually list the name as Yali Shen or Shen Y.
Selected publications
64 papers on PubMed matched by name and affiliation; 15 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Appl Clin Med Phys, 2024 (senior author): Deep learning based clinical target volumes contouring for prostate cancer: Easy and efficient application. PubMed 39120487
- Med Phys, 2024 (senior author): Efficient application of deep learning-based elective lymph node regions delineation for pelvic malignancies. PubMed 39072765
- Sichuan Da Xue Xue Bao Yi Xue Ban, 2024 (senior author): [Clinicopathological Features and Outcomes of Perioperative Treatment for Small Cell Carcinoma of the Bladder]. PubMed 39507967
- Comput Med Imaging Graph, 2024 (senior author): Energy-guided diffusion model for CBCT-to-CT synthesis. PubMed 38320336
- Clin Transl Oncol, 2024 (senior author): Capecitabine/cisplatin combined with concurrent intensity-modulated radiation therapy: a feasible therapeutic strategy for anal squamous cell carcinoma. PubMed 37568008
- BMJ Open, 2024 (senior author): Bladder sparing by short-course radiotherapy combined with toripalimab in high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study protocol for a single-arm, prospective, phase II trial. PubMed 38262639
- Front Oncol, 2023 (senior author): RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2-positive locally advanced muscle-invasive urothelial bladder cancer: a multi-center phase Ib/II study (HOPE-03). PubMed 38269021
- J Oncol, 2022 (senior author): Long-Term Follow-Up Results of Adjuvant Intensity-Modulated Radiotherapy with Concurrent Paclitaxel and Cisplatin in High-Risk Endometrial Cancer Patients. PubMed 36268278
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion